YU42700A - Novi aromatični amidi, njihov postupak dobijanja i primena kao lekova - Google Patents
Novi aromatični amidi, njihov postupak dobijanja i primena kao lekovaInfo
- Publication number
- YU42700A YU42700A YU42700A YU42700A YU42700A YU 42700 A YU42700 A YU 42700A YU 42700 A YU42700 A YU 42700A YU 42700 A YU42700 A YU 42700A YU 42700 A YU42700 A YU 42700A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- alkyl
- hydrogen
- aplication
- medicines
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/075—Benzo[b]pyran-2-ones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Pronalazak se odnosi na jedinjenja formule (I), gde Y je kiseonik, N-Nalc1 ili NOalc2; X je vodonik, hidroksil, alkil, alkenil, alkinil, alkoksi, CONOR ili NRcRd; gde Rc i Rd su vodonik ili alkil; Z je vodonik, halogen ili slobodan eterifikovan ili esterifikovan OH; R2 je vodonik ili halogen; R3 je vodonik, alkil ili halogen; R je vodonik ili alkil; R1 je vodonik, alkil alkenil ili alkinil; R5 je vodonik ili O-alkil; R6 je alkil ili CH2-O alkil i R7 je vodonik ili alkil; ili R6 i R7 formiraju sa atomom ugljenika koji ih nosi ciklični radikal koji sadrži do 8 atoma ugljenika. Jedinjenja formule (I) imaju antibiotske osobine.[The invention concerns compounds of formula (I), in which Y is oxygen, N-Nalc1 or NOalc2; X represents hydrogen, hydroxyl, alkyl, alkenyl, alkynyl, alkoxy, CONOR or NRcRd, Rc and Rd being hydrogen or alkyl; Z represents hydrogen, halogen or free, etherified or esterified OH; R2 hydrogen or halogen; R3 hydrogen, alkyl or halogen; R hydrogen or alkyl; R1 hydrogen, alkyl, alkenyl or alkynyl; R5 hydrogen or O-alkyl; R6 alkyl or CH2-O-alkyl and R7 hydrogen or alkyl; or R6 and R7 form with the carbon atom which bears them a cyclic radical containing up to 8 carbon atoms. The compounds of formula (I) have antibiotic properties.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9800116A FR2773369B1 (fr) | 1998-01-08 | 1998-01-08 | Nouveaux amides aromatiques, leur procede de preparation et leur application comme medicaments |
| FR9812936A FR2784681B1 (fr) | 1998-10-15 | 1998-10-15 | Nouveaux amides aromatiques, leur procede de preparation et leur application comme medicaments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU42700A true YU42700A (sh) | 2002-12-10 |
| RS50047B RS50047B (sr) | 2008-11-28 |
Family
ID=26234055
Country Status (36)
| Country | Link |
|---|---|
| US (2) | US6420538B1 (sh) |
| EP (1) | EP1045856B1 (sh) |
| JP (1) | JP2002500229A (sh) |
| KR (1) | KR100604290B1 (sh) |
| CN (2) | CN1257164C (sh) |
| AP (1) | AP2000001857A0 (sh) |
| AR (1) | AR015211A1 (sh) |
| AT (1) | ATE236918T1 (sh) |
| AU (1) | AU750742B2 (sh) |
| BR (1) | BR9906819A (sh) |
| CA (1) | CA2317951A1 (sh) |
| CO (1) | CO4810298A1 (sh) |
| CZ (1) | CZ299840B6 (sh) |
| DE (1) | DE69906684T2 (sh) |
| DK (1) | DK1045856T3 (sh) |
| DZ (1) | DZ2702A1 (sh) |
| EA (1) | EA003275B1 (sh) |
| ES (1) | ES2192031T3 (sh) |
| HU (1) | HUP0100847A3 (sh) |
| ID (1) | ID27558A (sh) |
| IL (1) | IL137201A0 (sh) |
| MA (1) | MA26593A1 (sh) |
| NO (1) | NO20003496L (sh) |
| NZ (1) | NZ505523A (sh) |
| PA (1) | PA8466601A1 (sh) |
| PE (1) | PE20000175A1 (sh) |
| PL (1) | PL193130B1 (sh) |
| PT (1) | PT1045856E (sh) |
| RS (1) | RS50047B (sh) |
| SA (1) | SA99191247B1 (sh) |
| SI (1) | SI1045856T1 (sh) |
| SK (1) | SK284734B6 (sh) |
| TN (1) | TNSN99003A1 (sh) |
| TR (1) | TR200002009T2 (sh) |
| TW (1) | TW538046B (sh) |
| WO (1) | WO1999035155A1 (sh) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2749585B1 (fr) * | 1996-06-11 | 1998-08-14 | Hoechst Marion Roussel Inc | Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments |
| TW538046B (en) * | 1998-01-08 | 2003-06-21 | Hoechst Marion Roussel Inc | Aromatic amides having antiobiotic activities and the preparation processes, intermediates and pharmaceutical composition thereof |
| US6916846B2 (en) | 2000-05-12 | 2005-07-12 | Merck & Co. Inc. | Coumermycin analogs as chemical dimerizers of chimeric proteins |
| PL362691A1 (en) | 2000-12-15 | 2004-11-02 | Vertex Pharmaceuticals Incorporated | Bacterial gyrase inhibitors and uses thereof |
| FR2844273B1 (fr) * | 2002-09-05 | 2008-04-04 | Aventis Pharma Sa | Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens. |
| US7439253B2 (en) * | 2002-12-06 | 2008-10-21 | Novexel | Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors |
| US8193352B2 (en) | 2003-01-31 | 2012-06-05 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
| US7569591B2 (en) | 2003-01-31 | 2009-08-04 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
| US8404852B2 (en) | 2003-01-31 | 2013-03-26 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
| US7618974B2 (en) | 2003-01-31 | 2009-11-17 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
| US7582641B2 (en) | 2003-01-31 | 2009-09-01 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
| AR042956A1 (es) | 2003-01-31 | 2005-07-13 | Vertex Pharma | Inhibidores de girasa y usos de los mismos |
| TW201026695A (en) | 2008-12-12 | 2010-07-16 | Astrazeneca Ab | Piperidine compounds and uses thereof-596 |
| TW201026694A (en) | 2008-12-12 | 2010-07-16 | Astrazeneca Ab | Compound 468 |
| TW201102065A (en) | 2009-05-29 | 2011-01-16 | Astrazeneca Ab | Heterocyclic urea derivatives and methods of use thereof |
| AR077971A1 (es) | 2009-08-26 | 2011-10-05 | Astrazeneca Ab | Derivados heterociclicos de urea y metodos de uso de los mismos |
| WO2011026107A1 (en) | 2009-08-31 | 2011-03-03 | University Of Notre Dame Du Lac | Phthalanilate compounds and methods of use |
| MX355561B (es) | 2011-01-14 | 2018-04-23 | Spero Trinem Inc | Proceso para hacer inhibidores de girasa y topoisomerasa iv. |
| AU2012205419B2 (en) | 2011-01-14 | 2016-12-15 | Spero Therapeutics, Inc. | Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl) pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea |
| EP2663557B1 (en) | 2011-01-14 | 2015-05-27 | Vertex Pharmaceuticals Incorporated | Pyrimidine gyrase and topoisomerase iv inhibitors |
| RU2013137753A (ru) | 2011-01-14 | 2015-02-20 | Вертекс Фармасьютикалз Инкорпорейтед | Твердые формы ингибитора гиразы (r)-1-этил-3-[5-[2-(1-гидрокси-1-метилэтил)пиримидин-5-ил]-7-(тетрагидрофуран-2-ил)-1н-бензимидазол-2-ил]мочевины |
| US9125922B2 (en) | 2011-06-20 | 2015-09-08 | Vertex Pharmaceuticals Incorporated | Phosphate esters of gyrase and topoisomerase inhibitors |
| TWI595002B (zh) | 2012-07-18 | 2017-08-11 | 思沛羅三南公司 | （Ｒ）－２－（５－（２－（３－乙基脲基）－６－氟－７－（四氫呋喃－２－基）－１Ｈ－苯并［ｄ］咪唑－５－基）嘧啶－２－基）丙烷－２－基磷酸二氫鹽之固體形式及其鹽 |
| US9572809B2 (en) | 2012-07-18 | 2017-02-21 | Spero Trinem, Inc. | Combination therapy to treat Mycobacterium diseases |
| US20210323957A1 (en) | 2018-09-03 | 2021-10-21 | Univerza V Ljubljani | New class of dna gyrase and/or topoisomerase iv inhibitors with activity against gram-positive and gram-negative bacteria |
| EP4263503A1 (en) | 2020-12-17 | 2023-10-25 | Univerza V Ljubljani | New n-phenylpyrrolamide inhibitors of dna gyrase and topoisomerase iv with antibacterial activity |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4226978A (en) | 1978-03-13 | 1980-10-07 | Miles Laboratories, Inc. | β-Galactosyl-umbelliferone-labeled aminoglycoside antibiotics and intermediates in their preparation |
| KR20000064710A (ko) | 1996-03-20 | 2000-11-06 | 제넨테크, 인코포레이티드 | 인테그린, 특히 ανβ3 인테그린에 대하여 특이 활성을갖는 3환식 화합물, 그 제조방법 및 그 제조를 위한 중간체, 의약으로서의 그 용도 및 그를 포함한 약제 조성물 |
| FR2749585B1 (fr) * | 1996-06-11 | 1998-08-14 | Hoechst Marion Roussel Inc | Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments |
| TW538046B (en) * | 1998-01-08 | 2003-06-21 | Hoechst Marion Roussel Inc | Aromatic amides having antiobiotic activities and the preparation processes, intermediates and pharmaceutical composition thereof |
-
1998
- 1998-12-18 TW TW087121194A patent/TW538046B/zh not_active IP Right Cessation
-
1999
- 1999-01-06 MA MA25418A patent/MA26593A1/fr unknown
- 1999-01-06 DZ DZ990003A patent/DZ2702A1/xx active
- 1999-01-07 IL IL13720199A patent/IL137201A0/xx unknown
- 1999-01-07 EP EP99900500A patent/EP1045856B1/fr not_active Expired - Lifetime
- 1999-01-07 JP JP2000527551A patent/JP2002500229A/ja active Pending
- 1999-01-07 PA PA19998466601A patent/PA8466601A1/es unknown
- 1999-01-07 US US09/600,053 patent/US6420538B1/en not_active Expired - Fee Related
- 1999-01-07 WO PCT/FR1999/000014 patent/WO1999035155A1/fr active IP Right Grant
- 1999-01-07 HU HU0100847A patent/HUP0100847A3/hu unknown
- 1999-01-07 ES ES99900500T patent/ES2192031T3/es not_active Expired - Lifetime
- 1999-01-07 SI SI9930174T patent/SI1045856T1/xx unknown
- 1999-01-07 DK DK99900500T patent/DK1045856T3/da active
- 1999-01-07 EA EA200000749A patent/EA003275B1/ru not_active IP Right Cessation
- 1999-01-07 RS YUP-427/00A patent/RS50047B/sr unknown
- 1999-01-07 AP APAP/P/2000/001857A patent/AP2000001857A0/en unknown
- 1999-01-07 PT PT99900500T patent/PT1045856E/pt unknown
- 1999-01-07 ID IDW20001325A patent/ID27558A/id unknown
- 1999-01-07 BR BR9906819-2A patent/BR9906819A/pt not_active Application Discontinuation
- 1999-01-07 TR TR2000/02009T patent/TR200002009T2/xx unknown
- 1999-01-07 NZ NZ505523A patent/NZ505523A/xx unknown
- 1999-01-07 AT AT99900500T patent/ATE236918T1/de not_active IP Right Cessation
- 1999-01-07 AU AU19736/99A patent/AU750742B2/en not_active Revoked
- 1999-01-07 CN CNB2003101141348A patent/CN1257164C/zh not_active Expired - Fee Related
- 1999-01-07 DE DE69906684T patent/DE69906684T2/de not_active Expired - Fee Related
- 1999-01-07 KR KR1020007007523A patent/KR100604290B1/ko not_active IP Right Cessation
- 1999-01-07 CN CNB998035033A patent/CN1269833C/zh not_active Expired - Fee Related
- 1999-01-07 CA CA002317951A patent/CA2317951A1/fr not_active Abandoned
- 1999-01-07 CZ CZ20002523A patent/CZ299840B6/cs not_active IP Right Cessation
- 1999-01-07 SK SK1015-2000A patent/SK284734B6/sk not_active IP Right Cessation
- 1999-01-08 TN TNTNSN99003A patent/TNSN99003A1/fr unknown
- 1999-01-08 CO CO99001031A patent/CO4810298A1/es unknown
- 1999-01-08 PE PE1999000017A patent/PE20000175A1/es not_active Application Discontinuation
- 1999-01-08 AR ARP990100061A patent/AR015211A1/es not_active Application Discontinuation
- 1999-04-05 SA SA99191247A patent/SA99191247B1/ar unknown
-
2000
- 2000-07-07 NO NO20003496A patent/NO20003496L/no not_active Application Discontinuation
- 2000-08-31 PL PL341590A patent/PL193130B1/pl not_active IP Right Cessation
-
2002
- 2002-06-05 US US10/162,852 patent/US6583119B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU42700A (sh) | Novi aromatični amidi, njihov postupak dobijanja i primena kao lekova | |
| MX9704449A (es) | Compuestos de aminosilano en composiciones de caucho cargadas con silice. | |
| EP1338603A4 (en) | NEW PYRAZONE DERIVATIVES AND AGENTS CONTAINING THEM AGAINST DIABETES | |
| ES2004310A6 (es) | Un metodo para modificar la superficie de silice finamente dividida | |
| EG18944A (en) | (Benzylidene) - Azolylmethylcycloalkane and use as fungicide | |
| HU9203024D0 (en) | Logical toy | |
| IL114726A0 (en) | Noribogaine derivatives and pharmaceutical compositions containing the same | |
| MX9605762A (es) | Fotoiniciadores de borato a partir de poliboranos. | |
| GR3005072T3 (sh) | ||
| GR3007983T3 (sh) | ||
| IE851241L (en) | Cephalosporins and analogues thereof | |
| EP0368933A4 (en) | COMPOSITIONS COMPRISING AZACYCLOALCANES SUBSTITUTED BY 1-OXO-HYDROCARBYL OR THIOHYDROCARBYL. | |
| EP0947504A4 (sh) | ||
| TW328094B (en) | Phthalimidylazo dyes, process for their preparation and the use thereof | |
| MX9505054A (es) | Derivados de ester de bisfenol. | |
| TW325498B (en) | Monocarbonates, use thereof and process for the preparation of compositions containing monocarbonates | |
| ZA934012B (en) | Antitumoral compounds. | |
| MY106839A (en) | Carboxylate compounds, liquid crystal compositions containing said compounds and liquid crystal elements. | |
| GB2271718B (en) | Antimicrobial agents comprising polyquaternary ammonium compounds | |
| JO2079B1 (en) | New amide aromat, method of preparation and use as a treatment | |
| EP0758309A4 (en) | CEMENT-BASED COMPOSITION | |
| TW328083B (en) | New derivatives of β-methoxy acrylic acid, their preparation process and their use as pesticides | |
| TW336234B (en) | Compounds derived from oxazolidin-2-one, their process of preparation and their application in therapeutics | |
| HUT76060A (en) | A process for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives | |
| IL131380A0 (en) | The use of a compound for the manufacture of a pharmaceutical preparatin for the treatment or prevention of prostate cancer |